New Insights into a Novel Metabolic Biomarker and Therapeutic Target for Chronic Kidney Disease

Abstract excerpt

Chronic kidney disease (CKD) affects approximately 13% of the global population.[1] CKD contributes to kidney dysfunction and eventually progresses to end-stage kidney disease. In its early stages, CKD is often asymptomatic, with kidney function decline and proteinuria occurring in later stages. However, once CKD advances, kidney function is significantly reduced, necessitating dialysis or a transplant.[2] This un...

Topics

Open a Topic to create a Post that cites this publication.

• Chronic Kidney Disease and Diabetes
• Hormonal Regulation and Hypertension
• Liver Disease Diagnosis and Treatment

Identifiers and source

Literature Corpus work

2f58203c-cec3-569b-ada1-9386c0bd5c21

DOI

10.1097/imna-d-24-00019